Related Experiment Video

Updated: Jun 13, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

898

Emerging role of tumor microenvironmental nutrients and metabolic molecules in ferroptosis: Mechanisms and clinical

Dongyu Li1, Zhe Zhang2, Lei Wang3

  • 1Department of VIP In-Patient Ward, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|September 10, 2024
PubMed

Insights

Ferroptosis, a cell death pathway, is crucial in cancer. Understanding how the tumor microenvironment influences ferroptosis resistance is key to improving cancer treatment and drug sensitivity.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Ferroptosis is a regulated cell death pathway increasingly recognized for its role in cancer.
  • Ferroptosis resistance contributes significantly to tumor metastasis, recurrence, and therapeutic drug resistance.
  • Targeting ferroptosis mechanisms is a critical strategy for inhibiting tumor progression and enhancing drug sensitivity.

Purpose of the Study:

  • To review the characteristics of the tumor microenvironment (TME).
  • To summarize the mechanisms of ferroptosis induction and resistance under various TME factors.
  • To explore novel therapeutic strategies for sensitizing tumor cells to anticancer drugs via ferroptosis modulation.

Main Methods:

  • Literature review focusing on ferroptosis and the tumor microenvironment.
  • Analysis of environmental factors within the TME (e.g., hypoxia, lactic acid) and their impact on ferroptosis.
  • Examination of ferroptosis mechanisms in the context of anticancer drug action.

Main Results:

  • The TME significantly influences tumor cell biological functions, including ferroptosis.
  • Abnormal TME characteristics like hypoxia and lactic acid accumulation are linked to ferroptosis resistance.
  • Anticancer drugs can interact with TME components to affect ferroptosis.

Conclusions:

  • Understanding TME-mediated ferroptosis is essential for developing effective cancer therapies.
  • Targeting ferroptosis pathways within the TME offers promising strategies for overcoming drug resistance and improving patient outcomes.
  • Further research into the interplay between the TME, ferroptosis, and drug response is warranted.
Keywords:
Drug resistanceFerroptosisHypoxiaLactateTME

More Related Videos

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

856
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.5K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K